Breaking News
March 18, 2018 - Jobs That Keep the Mind Sharp … Even Into Retirement
March 18, 2018 - Facial Scarring Improved with Botulinum Toxin
March 18, 2018 - Data detectives shift suspicions in Alzheimer’s to inside villain
March 18, 2018 - Shorter Preventive TB Tx Effective for HIV+ Patients
March 18, 2018 - New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips
March 18, 2018 - Researchers uncover four microRNAs as potential biomarkers for atrial fibrillation
March 18, 2018 - IRX Therapeutics Announces Initiation of Phase 2 Clinical Trial of IRX-2 in Squamous Cervical or Vulvar Intraepithelial Neoplasia 3
March 18, 2018 - OncoBreak: Learning from Silence; ‘Rigged’ Drug System; NCCN Guidelines Questioned
March 18, 2018 - The coffee cannabis connection
March 18, 2018 - Novel centrifugal-flow pump for heart failure patients provides improved long-term outcomes
March 18, 2018 - U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
March 18, 2018 - Cath Lab Recap: iFR vs FFR $$; Ridaforolimus-Eluting Stent
March 18, 2018 - Tree care workers need better training to handle dangers on the job, study finds
March 18, 2018 - Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds
March 18, 2018 - Transplanting enhanced interneurons restores brain rhythms in mouse model of Alzheimer’s
March 18, 2018 - Gene Therapy Flops for Critical Limb Ischemia
March 17, 2018 - Study spotlights risks in anesthesiologist handoffs
March 17, 2018 - Verb fluency test may be useful tool for differential diagnosis of cognitive failure
March 17, 2018 - Health Tip: Suggestions to Improve Your Cholesterol
March 17, 2018 - Fructans Suspect in Non-Celiac Gluten Sensitivity
March 17, 2018 - Aspirin therapy appears safe before thyroid surgery
March 17, 2018 - Minimally invasive surgical device may one day provide lasting heart repair
March 17, 2018 - UIH and RaySearch enter into new partnership
March 17, 2018 - Is BMI Too Inexact? | Medpage Today
March 17, 2018 - Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms
March 17, 2018 - Leicester research could help identify people with asthma of different severities
March 17, 2018 - Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter
March 17, 2018 - Participants in rogue herpes vaccine research take legal action
March 17, 2018 - Imara Doses First Patient in Phase 2a Clinical Trial of IMR-687 for Sickle Cell Disease
March 17, 2018 - AAP: Prevent Medication Errors by Improving Processes
March 17, 2018 - Severe sleep apnea during REM sleep tied to acute CV events
March 17, 2018 - Alzheimer’s disease also affects small blood vessels
March 17, 2018 - Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 17, 2018 - Switching Biologics in Psoriasis Care
March 17, 2018 - Polygenic risk score may identify alzheimer’s risk in younger populations
March 17, 2018 - Genetic heart mutations account for fewer sudden and unexplained infant deaths
March 17, 2018 - Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration
March 17, 2018 - Researchers team up to improve life for children with microcephaly
March 17, 2018 - Health guide for young women regarding labiaplasty
March 17, 2018 - Inhaled Nitrite Flops as HFpEF Therapy
March 17, 2018 - California mental health tax providing services to needy in L.A. County, study finds
March 17, 2018 - Cancer survivors become fatigued more quickly than their peers, study finds
March 17, 2018 - Study finds common presence of nightmares among U.S. military personnel
March 17, 2018 - Yellow fever outbreak in Brazil necessitates vaccination for travelers
March 17, 2018 - Health Tip: Waist Size May Help Predict Heart Attack
March 17, 2018 - Low-Dose Combo Pill Successfully Takes Down High BP
March 17, 2018 - Most children with sickle cell anemia not receiving key medication to stay healthy
March 17, 2018 - YCC launches new Yale Center for Immuno-Oncology
March 17, 2018 - My Job Isn’t to Move Patients Quickly
March 17, 2018 - Achoo! Cold, Flu, or Something Else?
March 17, 2018 - For girls who mature early, psychological problems last into adulthood
March 17, 2018 - Researchers find new method to restore movement sensation in patients with prosthetic arms
March 17, 2018 - Older patients with colorectal cancer at increased risk of cardiovascular morbidity
March 17, 2018 - Chemical peels can be safe treatment option for people with darker skin
March 17, 2018 - Rutgers University study highlights the need for improved safety in tree-care operations
March 17, 2018 - Review reveals essential themes for successful care transitions for persons with dementia
March 17, 2018 - Subset of immune cells critical for ensuring healthy weight gain, study shows
March 17, 2018 - Genetic variant discovery could improve safety, effectiveness of drugs for asthma and COPD
March 17, 2018 - New 3D tissue model of developing heart could be used to test safety of drugs during pregnancy
March 17, 2018 - Study on infant bone strength could aid in design of safer car seats
March 17, 2018 - Online program increases depression treatment rates among adolescent mothers
March 17, 2018 - Pulmatrix Announces First Subject Dosed in Phase 1 Clinical Trial of Pulmazole – an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole
March 17, 2018 - Diet During Pregnancy May Cut Offspring Allergy Risk
March 17, 2018 - Faulty cellular membrane ‘mix’ linked to Parkinson’s disease
March 17, 2018 - For aspiring doctors with disabilities, many medical schools come up short
March 17, 2018 - Common genetic variation shown to increase Alzheimer’s risk
March 17, 2018 - Switching to glo vapor reverses biological effects caused by smoke exposure
March 16, 2018 - Climate change spurs proliferation of disease-bearing insects, increases exposure to viral infections
March 16, 2018 - FDA Accepts Remoxy NDA For Review
March 16, 2018 - Docs to the Rescue? | Medpage Today
March 16, 2018 - Shedding a tear may help diagnose Parkinson’s disease
March 16, 2018 - Study elucidates underlying cause of brain injury in stroke
March 16, 2018 - Neuroscientists identify role of primary visual cortex in integrating head and visual movement signals
March 16, 2018 - MIT engineers develop new technology that could improve drug evaluation
March 16, 2018 - IBN’s green tea-based drug nanocarriers show superior tumor-killing performance
March 16, 2018 - NIH researchers explore genetic clocks to understand role of aging in neurodegeneration
March 16, 2018 - FDA Alert: Alka-Seltzer Plus Products: Recall
March 16, 2018 - DOJ Repeats Threat to Hold Opioid Prescribers Accountable
March 16, 2018 - PFASs, chemicals commonly found in environment, may interfere with body weight regulation
March 16, 2018 - Study reveals reduced risk of dementia for physically fit women
YCC researchers propose new patient selection methods for breast cancer clinical trials

YCC researchers propose new patient selection methods for breast cancer clinical trials

image_pdfDownload PDFimage_print

Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years. Now Yale Cancer Center (YCC) investigators have demonstrated in a new study that more sophisticated models to assess patient risk for cancer can result in better clinical trials with more definitive results.

Often the problems with clinical trials begin in patient selection methods that underestimate how many of these patients can be treated successfully with standard-of-care therapies, and won’t benefit from a more effective drug under study.

Many factors contribute to a breast cancer patient’s risks of recurrence or death from the disease, including tumor size, presence of cancer in lymph nodes, patient age, and their overall health. “Historically, clinical trials select patients using mostly tumor size and lymph node status,” said Lajos Pusztai, M.D., DPhil, senior corresponding author of a study published in JAMA Oncology and chief of Breast Medical Oncology at YCC.

All too often, the result is that patients included in the control arm of a trial who receive standard-of-care treatment experience too few “events” — cancer recurrences or deaths — to allow statistically conclusive comparisons with patients receiving experimental therapy. “If there are not enough events, one can miss a truly effective drug that could help patients who remain at risk for recurrence despite current best therapies,” said Pusztai.

This problem can be avoided by employing a statistical model that combines multiple variables such as tumor size, lymph-node status, and benefit from standard-of-care therapy into a single score that corresponds to the predicted risk of recurrence after receiving current best therapies.

“Several such models exist that have been extensively validated and predict fairly accurately the likelihood that an individual will experience an event,” Pusztai said. Using this risk score to select patients with predefined minimum risk of recurrence (such as 25% or greater risk of recurrence in five years) ensures that the control arm has the required number of events for statistically sound comparisons.

The YCC researchers performed simulations for randomized, two-arm breast cancer adjuvant trials that compared traditional patient selection methods based on tumor size and lymph node status with patient selection based on minimal risk of recurrence generated by a widely used risk prediction model known as AdjuvantOnline. “We showed that the range of event rates varies very broadly if you use the traditional method of selecting patients, and a particular trial may end up with substantially lower events than intended by the statistical design,” Pusztai explained.

In contrast, with statistically validated multivariant risk models, “we can select patients who really require clinical trials because their outcome with current treatments is less than optimal,” Pusztai said. “This approach guarantees that the statistical power of the study is adequate to demonstrate if the new treatment is really effective or not. We also can expose fewer patients to the side effects of the new treatment. That’s good for the patients.”

“Our residual risk-based selection method also renders trials more efficient and cost-effective for drug companies, because it allows smaller studies with more guaranteed statistically power to succeed,” he added.

This approach could benefit clinical trials for other types of cancer as well for which validated multivariant risk prediction models already exist, Pusztai noted.

Tagged with:

About author

Related Articles